Celmatix’s Post

Sharing with you my interview with Tasha Jennings on the Conceive Baby podcast! With the topic of International Hope for Couples Facing Fertility Challenges, I talked about how advancements in reproductive medicine offer new possibilities for hopeful parents around the globe. Always happy to share insights gained from years of pioneering work in assisted reproduction technologies at Ovogene, shedding light on the ethical considerations, misconceptions, and advancements driving this field forward, including the role of AI technology. I invite you to tune in, learn, and engage with us on this discussion. And if you have any questions or wish to connect further, don't hesitate to reach out!

This week's episode of the Tradeoffs podcast explores what role and impact private equity has in different health care sectors. Researchers find that corporate investment improves outcomes in IVF while at the same time worsening outcomes for nursing home patients. We explore the reasons for those differences and how that could inform regulation. Listen now: https://lnkd.in/g_us6CMU

🎙️ Must-Listen: Empowering Women through Pelvic Health 🎙️ The episode from FemHealth Insights and Nyoo Health is all about women's health and empowerment. Tune in to this enlightening podcast episode as they discuss the challenges in medicine, the social stigma around pelvic health, and why women must prioritize it as self-care. Pelihealth cannot say enough good things about this panel. #pelvichealth #womenshealth

Pronatalism, especially as propagated by the unbelievably well-financed #IVF industry, is so pervasive & powerful that even those who don't want kids can fall prey! Hear our podcast guest Sara's inspiring story of relief after IVF failure https://ow.ly/S2GK50TxFk9

Pronatalism, especially as propagated by the unbelievably well-financed #IVF industry, is so pervasive & powerful that even those who don't want kids can fall prey! Hear our podcast guest Sara's inspiring story of relief after IVF failure https://ow.ly/S2GK50TxFk9

Please do check out the in-depth piece on the need for improved diagnosis of endometriosis featured in The Mail on Sunday today. https://lnkd.in/equfBMY9 The article highlights the ongoing Serac Healthcare and University of Oxford research which is testing our imaging agent, maraciclatide, as a potential tool for assessing endometriosis. With huge thanks to Dr Tatjana Gibbons from the Nuffield Dept of Women's & Reproductive Health, University of Oxford, investigator on the DETECT study, for setting out the case so clearly as to why there is such an unmet diagnostic need for this extremely painful condition which affects 1 in 10 women of reproductive age.   #endometriosis #womenshealth #molecularimaging #diagnosticimaging Krina Zondervan  

💡 Every sponsor should do their features like how Embie Clinic did with Mark Amols, MD and Elizabeth Lee, B.Sc., R.N. 1. Build a product from both the #ivf patient and the #fertilityclinic’s point of view (and lab) 2. Make it good enough until at least a couple people love, not like, it 3. Send those people onto the podcast, without you 4. Let them open up the product (demo, offering, value proposition service) and share what problems it solves for them—not what you like about it 5. Don’t edit out my skepticism. It’s healthy, and impersonal: it’s insanely hard to provide value in the marketplace and I want to see how you’re struggling to do so. — Ravid Israel Josh Gottesman

👉 Breaking the Mould: From 'Femtech' to 'DiagnosTech' We've been navigating the landscape of women's health, and can't help but express our frustration at the broad brushstroke term 'Femtech.' It seems to lump everything related to women's health into a single, cutesy category, regardless of the critical distinctions between reproductive health, diagnostic care or menstrual products. Should everything fit into one category, whether it’s medicine or mooncups? At Hertility, we believe it's time to break free from this label and give our mission the specificity it deserves. We are proud to introduce 'DiagnosTech' – a term that encapsulates the core of what we do and emphasises our commitment to diagnostic excellence. 👉 Why 'DiagnosTech'? Hertility is about empowering women through next-generation diagnostics. Our capabilities extend far beyond conventional reproductive health solutions. We leverage predictive algorithms, cutting-edge data analytics, and AI to revolutionise testing, consultations, and aftercare. We are a research lead company whose clinical and scientific team spans over 70 years of experience. We have presented over 30 abstracts at national and international scientific conferences. Our team of experts include clinicians, scientists and statisticians with years of experience in genetics, obstetrics, gynaecology, polycystic ovary syndrome (PCOS), endometriosis and more. 👉 Key Features of Hertility - Diagnostic Capabilities 🔍 Our advanced diagnostics go beyond traditional tests, providing diagnostic capabilities across over 18 reproductive health conditions and comprehensive insights into reproductive health, fertility, and overall well-being. - Predictive Algorithms 🚀 We utilise state-of-the-art predictive algorithms to anticipate potential health issues, enabling proactive and personalised care. - Data and AI Integration 📊 Harnessing the power of data and AI, we ensure that our testing, consultations, and aftercare are at the forefront of innovation and accuracy. 👉 Our Commitment Hertility Health is committed to reshaping the narrative around women's health. We believe that by focusing on precision diagnostics, we can empower individuals to make informed decisions about their health and well-being. It's time to move beyond the confines of 'Femtech' and embrace the specificity of 'DiagnosTech.' Join us on this journey towards a future where women's health is defined by precision, innovation, and personalised care. Together, let's redefine the conversation around women's health. #DiagnosTech #ReproductiveRevolution #PrecisionDiagnostics #HealthcareInnovation #HertilityHealth #MotherOfAllMovements #FEMPIRE 💙

🚀 We released Pinky Promise v2 this week 🚀. This is one of the most unique and challenging things I have built to date. I am very excited to see it go out into the world. In Jan 2023 Pinky Promise launched a basic version of this product covering three of the most commonly occurring reproductive health issues, and in one year we consulted for over 10K patients. Using many lessons from this, in the last two months we have expanded to 97% of all reproductive healthcare issues. Here are some of the big changes and the technologies behind this: 1. 🏥 Using over 250 of the top medical protocols in the world, carefully curated by our medical team, we are fine-tuning top medical LLM algorithms to create a medical decision making system biased towards women. Our patients come on the app and start by describing their symptoms, and within 5-10 mins of starting they have a Doctor-approved prescription in hand. We track Doctor edits and patient cure-rates to feed data back into this system and keep it improving. 2. 👩🏼⚕️ Once the patient receives the prescription, they are connected with their Doctor over chat throughout their care journey. To enable Doctor's to reply in near-realtime, we have built a Chat-GPT based copilot which suggests answers to all the Patient's questions. 3. 📱 We have rebuilt our app on flutter and is now available on Web, Android and iOS. 4. 💬 One of our biggest learnings so far has been that our target market is most comfortable with "chat". This product has been build on top of DialogFlow as a chatbot. Whether they are describing their symptoms or answering questions about their medical history, or booking tests - they can just chat with us. This sets the stage to seamlessly expand setting to provide instant reatime care on any platform (whatsapp / Alexa / sms) and across languages in the future. This is a launchpad for us. We are fast expanding our offerings to provide tools for the larger medical ecosystem and enable are patients to manage their health in an easy and cohesive manner that is anxiety free and proactive. Indian women don't go to Doctor's (including me). This is a huge step towards changing that. A huge huge shoutout to Divya Balaji Kamerkar, Dr. Reema Shah, Feya Shah, Shreeya Sethi, Anam Sajan, the entire Flair Labs team for pulling this off in record time! Do check it out we would love feedback and to chat about this journey! https://lnkd.in/d2juWaRd

In the newest episode of the Keep IT Healthy podcast, we explore Amy Beckley PhD’s fascinating story—a reproductive health trailblazer. Amy has a PhD in pharmacology and a plethora of expertise in developing vaccines and finding cancer drugs. Her career took a personal turn when she became infertile. She was motivated to develop Proov, an FDA-cleared home diagnostic test that gauges hormone levels to determine fertility. Since then, Proov has transformed how women view and handle reproductive health by providing an approachable, user-friendly answer to a difficult issue. Interesting? We bet! Don't miss it then, and listen to the whole episode! #femtech #healthtech #fertility #homediagnostic